Morin Hydrate Mitigates Cisplatin-Induced Renal and Hepatic Injury by Impeding Oxidative/Nitrosative Stress and Inflammation in Mice

Journal of Biochemical and Molecular Toxicology

Volumn 30, Issue 12, 2016, Pages 571-579

  Athira, K V ^a   Madhana, Rajaram Mohanrao ^a   Kasala, Eshvendar Reddy ^a   Samudrala, Pavan Kumar ^a   Lahkar, Mangala ^a,b   Gogoi, Ranadeep ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^b GAUHATI MEDICAL COLLEGE   (India)

Author keywords

Cisplatin; Inflammation; Morin Hydrate; Oxidative nitrosative Stress; Toxicity

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; CISPLATIN; CREATININE; FREE RADICAL; MORIN; MORIN HYDRATE; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; FLAVONOID; INTERLEUKIN 6; INTERLEUKIN-6, MOUSE; TUMOR NECROSIS FACTOR;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BIOCHEMICAL ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HISTOPATHOLOGY; INFLAMMATION; LIVER HISTOLOGY; LIVER TOXICITY; MORTALITY; MOUSE; NEPHROTOXICITY; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; TISSUE PREPARATION; UREA NITROGEN BLOOD LEVEL; WEIGHT REDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CHEMICALLY INDUCED; DRUG ADMINISTRATION; DRUG EFFECTS; KIDNEY; LIVER; METABOLISM; NITROSATION; PATHOLOGY; TREATMENT OUTCOME;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CISPLATIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLAVONOIDS; INFLAMMATION; INTERLEUKIN-6; KIDNEY; LIVER; MICE; NITROSATION; OXIDATIVE STRESS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT LOSS;

EID: 84964262550     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.21817     Document Type: Article

References (37)

1. Delord J-P, Puozzo C, Lefresne F, Bugat R. Combination chemotherapy of vinorelbine and cisplatin: a phase I pharmacokinetic study in patients with metastatic solid tumors. Anticancer Res 2009;29(2):553–560.
2. Go RS, Adjei AA. Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin. J Clin Oncol 1999;17(1):409–409.
3. Yao X, Panichpisal K, Kurtzman N, Nugent K. Cisplatin nephrotoxicity: a review. Am J Med Sci 2007;334(2):115–124.
4. Cersosimo RJ. Hepatotoxicity associated with cisplatin chemotherapy. Ann Pharmacother 1993;27(4):438–441.
5. Ozols RF, Young RC. High-dose cisplatin therapy in ovarian cancer. Semin Oncol 1985;12(4 Suppl 6):21–30.
6. Zirak MR, Rahimian R, Ghazi-Khansari M, Abbasi A, Razmi A, Mehr SE, Mousavizadeh K, Dehpour AR. Tropisetron attenuates cisplatin-induced nephrotoxicity in mice. Eur J Pharmacol 2014;738:222–229.
7. Dkhil MA, Al-Quraishy S, Aref AM, Othman MS, El-Deib KM, Abdel Moneim AE. The potential role of Azadirachta indica treatment on cisplatin-induced hepatotoxicity and oxidative stress in female rats. Oxid Med Cell Longev 2013; 2013.
8. Almaghrabi OA. Molecular and biochemical investigations on the effect of quercetin on oxidative stress induced by cisplatin in rat kidney. Saudi J Biol Sci 2015;22(2):227–231.
9. Hagar H, El Medany A, Salam R, El Medany G, Nayal OA. Betaine supplementation mitigates cisplatin-induced nephrotoxicity by abrogation of oxidative/nitrosative stress and suppression of inflammation and apoptosis in rats. Exp Toxicol Pathol 2015;67(2):133–141.
10. Al-Malki AL, Sayed AAR. Thymoquinone attenuates cisplatin-induced hepatotoxicity via nuclear factor kappa-β. BMC Complement Altern Med 2014;14(1):282.
11. Rosenberg B, Charles F. Kettring prize. Fundamental studies with cisplatin. Cancer 1985;55(10):2303–2316.
12. Middleton E, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 2000;52(4):673–751.
13. Chtourou Y, Aouey B, Aroui S, Kebieche M, Fetoui H. Anti-apoptotic and anti-inflammatory effects of naringin on cisplatin-induced renal injury in the rat. Chem Biol Interact 2016,243:1–9.
14. Momeni A, Hajigholami A, Geshnizjani S, Kheiri S. Effect of silymarin in the prevention of cisplatin nephrotoxicity, a clinical trial study. J Clin Diagn Res 2015;9(4):OC11.
15. Tanaka T, Kawabata K, Kakumoto M, Makita H, Ushida J, Honjo S, Hara A, Tsuda H, Mori H. Modifying effects of a flavonoid morin on azoxymethane-induced large bowel tumorigenesis in rats. Carcinogenesis 1999;20(8):1477–1484.
16. Nandhakumar R, Salini K, Devaraj SN. Morin augments anticarcinogenic and antiproliferative efficacy against 7, 12-dimethylbenz (a)-anthracene induced experimental mammary carcinogenesis. Mol Cell Biochem 2012;64(1–2):79–92.
17. Kapoor R, Kakkar P. Protective role of morin, a flavonoid, against high glucose induced oxidative stress mediated apoptosis in primary rat hepatocytes. PLoS One 2012;7(8):e41663.
18. MadanKumar P, Naveen Kumar P, Devaraj H, Niranjali Devaraj S. Morin, a dietary flavonoid, exhibits anti-fibrotic effect and induces apoptosis of activated hepatic stellate cells by suppressing canonical NF-κB signaling. Biochimie 2015;110:107–118.
19. Prahalathan P, Kumar S, Raja B. Morin attenuates blood pressure and oxidative stress in deoxycorticosterone acetate-salt hypertensive rats: a biochemical and histopathological evaluation. Metabolism 2012;61(8):1087–1099.
20. Miyawaki Y, Ueki M, Ueno M, Asaga T, Tokuda M, Shirakami G. D-allose ameliorates cisplatin-induced nephrotoxicity in mice. Tohoku J Exp Med 2012;228(3):215–221.
21. Fouad AA, Al-Sultan AI, Refaie SM, Yacoubi MT. Coenzyme Q10 treatment ameliorates acute cisplatin nephrotoxicity in mice. Toxicology 2010;274(1):49–56.
22. Treskes M, Boven E, Holwerda U, Pinedo HM, van der Vijgh WJ. Time dependence of the selective modulation of cisplatin-induced nephrotoxicity by WR2721 in the mouse. Cancer Res 1992,52(8):2257–2260.
23. Winston JA, Safirstein R. Reduced renal blood flow in early cisplatin-induced acute renal failure in the rat. Am J Physiol Renal Physiol 1985;249(4):F490–F496.
24. Kharbangar A, Khynriam D, Prasad S. Effect of cisplatin on mitochondrial protein, glutathione, and succinate dehydrogenase in Dalton lymphoma-bearing mice. Cell Biol Toxicol 2000;16(6):363–373.
25. Sener MT, Sener E, Tok A, Polat B, Cinar I, Polat H, Akcay F, Suleyman H. Biochemical and histologic study of lethal cisplatin nephrotoxicity prevention by mirtazapine. Pharmacol Rep 2012;64(3):594–602.
26. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193(1):265–275.
27. Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 1968;25:192–205.
28. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95(2):351–358.
29. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15 N] nitrate in biological fluids. Anal Biochem 1982;126(1):131–138.
30. Chirino YI, Pedraza-Chaverri J. Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Exp Toxicol Pathol 2009;61(3):223–242.
31. Zhang Y, Yuan F, Cao X, Zhai Z, Du X, Wang Y, Huang Y, Zhao J, Hou W. P2X7 receptor blockade protects against cisplatin-induced nephrotoxicity in mice by decreasing the activities of inflammasome components, oxidative stress and caspase-3. Toxicol Appl Pharmacol 2014;281(1):1–10.
32. Subash S, Subramanian P. Morin a flavonoid exerts antioxidant potential in chronic hyperammonemic rats: a biochemical and histopathological study. Mol Cell Biochem 2009;327(1–2):153–161.
33. Collins T, Read M, Neish A, Whitley M, Thanos D, Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J 1995;9(10):899–909.
34. Malik S, Bhatia J, Suchal K, Gamad N, Dinda AK, Gupta YK, Arya DS. Nobiletin ameliorates cisplatin-induced acute kidney injury due to its anti-oxidant, anti-inflammatory and anti-apoptotic effects. Exp Toxicol Pathol 2015;67(7):427–433.
35. Ramesh G, Reeves WB. TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest 2002;110(6):835–842.
36. Sahu BD, Kalvala AK, Koneru M, Kumar JM, Kuncha M, Rachamalla SS, Sistla R. Ameliorative effect of fisetin on cisplatin-induced nephrotoxicity in rats via modulation of NF-κB activation and antioxidant defence. PLoS One 2014;9(9):e105070.
37. Sahu BD, Kumar JM, Sistla R. Baicalein, a bioflavonoid, prevents cisplatin-induced acute kidney injury by up-regulating antioxidant defenses and down-regulating the MAPKs and NF-κB pathways. PLoS One 2015;10(7):e0134139.